ReviewCurrent hematologic malignancy reports2024

Approach to the patient with eosinophilia in the era of tyrosine kinase inhibitors and biologicals.

Johannes Lübke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.